Predicting relapse after achieving a functional cure for chronic hepatitis B (CHB) using baseline HBsAg and end-of-treatment HBsAb levels
Abstract Among the factors influencing relapse after clinical cure of chronic hepatitis B(CHB). There is no standardization of baseline HBsAg levels and end-of-treatment HBsAb levels. This multicenter, retrospective study enrolled 136 patients who achieved functional cure from June 2019 to December...
Saved in:
| Main Authors: | Lianxiu Han, Zilong Wang, Luyang Kang, Xiaoling Cui, Yi Li, Huafa Yin, Yufeng Gao, Jiabin Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-86555-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
by: Shengxia Yin, et al.
Published: (2023-12-01) -
HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases
by: Zhongshu Pu, et al.
Published: (2025-05-01) -
Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region
by: Armel Moumouni Sanou, et al.
Published: (2018-11-01) -
Dynamics of HBsAb persistence and associated BCR IgG-H CDR3 repertoire features in ultra-high versus extremely low responders to HBV vaccination
by: Ting-Wen Yang, et al.
Published: (2025-07-01) -
Efficacy of extracorporeal immunoadsorption therapy for removal of HBsAg
by: Meng Wang, et al.
Published: (2025-07-01)